REGENCIN Trademark

Trademark Overview

On Wednesday, August 27, 2008, a trademark application was filed for REGENCIN with the United States Patent and Trademark Office. The USPTO has given the REGENCIN trademark a serial number of 77556565. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, September 17, 2008. This trademark is owned by Pfizer Inc.. The REGENCIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-aging and regenerative medicine preparations; pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, neuropathic pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; biological, biomedical and biochemical preparations and solutions, namely, cell preparations, enzymes, proteins, hormones, microbes, molecules and reagents
regencin

General Information

Serial Number77556565
Word MarkREGENCIN
Filing DateWednesday, August 27, 2008
Status601 - ABANDONED - EXPRESS
Status DateWednesday, September 17, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-aging and regenerative medicine preparations; pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, neuropathic pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; biological, biomedical and biochemical preparations and solutions, namely, cell preparations, enzymes, proteins, hormones, microbes, molecules and reagents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Wednesday, September 17, 2008ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Wednesday, September 17, 2008ABANDONMENT - EXPRESS MAILED
Tuesday, September 16, 2008TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, September 2, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

regencin preparations pharmaceutical namely dysfunction pain treatment diseases neuropathic aids antifungal